Bone morphogenetic protein 7 inhibits apoptosis of nucleus pulposus cells

doi:10.12307/2022.542

Abstract

Abstract: BACKGROUND: Disc degeneration is one of the major causes of lower back pain, and current clinical surgical treatments can relieve painful symptoms but sacrifice disc function and cannot completely cure disc degeneration. Therefore, it is important to develop new biological treatments to curb the progression of early disc degeneration, or to regenerate degenerated disc tissue.
OBJECTIVE: To investigate whether bone morphogenetic protein 7 can reduce the senescence of human nucleus pulposus cells during subculture and its possible mechanism.
METHODS: Patients who underwent discectomy were enrolled in this study. During the operation, the intervertebral disc tissue was obtained and human nucleus pulposus cells were extracted and subcultured in vitro for six times. The cells were then cultured with bone morphogenetic protein 7 or LY294002, a specific inhibitor of phosphatidyl-inositol 3-kinase. Cell proliferation ability, telomerase activity, β-galactosidase activity, and the expression of apoptosis-related genes and phosphatidyl-inositol 3-kinase/protein kinase B signaling pathway molecules were detected.
RESULTS AND CONCLUSION: Bone morphogenetic protein 7 could significantly increase the cell proliferation and telomerase activity of nucleus pulposus cells, decrease the activity of β-galactosidase, down-regulate the expression of p16 and p53, and activate phosphatidyl-inositol 3-kinase/protein kinase B signaling pathway. In addition, LY294002 could significantly reverse the anti-apoptotic effect of bone morphogenetic protein 7 on nucleus pulposus cells. Overall, bone morphogenetic protein 7 exerts the anti-apoptotic effect on nucleus pulposus cells by activating the phosphatidyl-inositol 3-kinase/protein kinase B signaling pathway. The results of this study can provide new knowledge for in vitro culture and tissue engineering of allogenic nucleus pulposus cells.

Key words: intervertebral disc regeneration, nucleus pulposus cells, bone morphogenetic protein 7, apoptosis

CLC Number:

Xu Xuezhen, Song Lixian, Li Aiqun, Yang Jian, Li Xiaokun, Wang Zhanqing, Shi Qingpeng. Bone morphogenetic protein 7 inhibits apoptosis of nucleus pulposus cells[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(17): 2726-2731.

Figures/Tables 4

References

[1] 邱晨生, 邓念, 相宏飞, 等. 椎间盘退变相关危险因素的研究进展[J]. 中华骨科杂志,2021,41(10):654-659.
[2] 陈敏, 赵凯. 椎间盘退变的机制及其治疗方法的研究进展[J]. 按摩与康复医学,2019,10(18):58-60.
[3] 余城墙, 张宇, 谢程欣, 等. 椎间盘退变分子生物学机制及再生治疗的优势与未来[J]. 中国组织工程研究,2019,23(30):4889-4896.
[4] VADALA G, RUSSO F, De STROBEL F, et al. Novel stepwise model of intervertebral disc degeneration with intact annulus fibrosus to test regeneration strategies. J Orthop Res. 2018;36(9):2460-2468.
[5] 陈铭, 沈军. 椎间盘髓核退变再生修复研究和临床应用现状[J]. 南京医科大学学报(自然科学版),2019,39(5):774-780.
[6] ZHAO K, AN R, XIANG Q, et al. Acid-sensing ion channels regulate nucleus pulposus cell inflammation and pyroptosis via the NLRP3 inflammasome in intervertebral disc degeneration. Cell Prolif. 2021; 54(1):e12941.
[7] WANG W, DENG G, QIU Y, et al. Transplantation of allogenic nucleus pulposus cells attenuates intervertebral disc degeneration by inhibiting apoptosis and increasing migration. Int J Mol Med. 2018;41(5):2553-2564.
[8] LIU J, YU J, JIANG W, et al. Targeting of CDKN1B by miR-222-3p may contribute to the development of intervertebral disc degeneration. FEBS Open Bio. 2019;9(4):728-735.
[9] MA K, CHEN S, LI Z, et al. Mechanisms of endogenous repair failure during intervertebral disc degeneration. Osteoarthritis Cartilage. 2019;27(1):41-48.
[10] WU Q, MATHERS C, WANG EW, et al. TGF-beta Initiates beta-Catenin-Mediated CTGF Secretory Pathway in Old Bovine Nucleus Pulposus Cells: A Potential Mechanism for Intervertebral Disc Degeneration. JBMR Plus. 2019;3(2):e10069.
[11] CHEN S, LIU S, MA K, et al. TGF-beta signaling in intervertebral disc health and disease. Osteoarthritis Cartilage. 2019;27(8):1109-1117.
[12] KROUWELS A, ILJAS JD, KRAGTEN A, et al. Bone Morphogenetic Proteins for Nucleus Pulposus Regeneration. Int J Mol Sci. 2020; 21(8):2720.
[13] LI Z, LANG G, KARFELD-SULZER LS, et al. Heterodimeric BMP-2/7 for nucleus pulposus regeneration-In vitro and ex vivo studies. J Orthop Res. 2017;35(1):51-60.
[14] MA K, CHEN S, LI Z, et al. Mechanisms of endogenous repair failure during intervertebral disc degeneration. Osteoarthritis Cartilage. 2019;27(1):41-48.
[15] De CICCO FL, CAMINO WG. Nucleus Pulposus Herniation. 2021.
[16] TAVAKOLI J, DIWAN AD, TIPPER JL. Elastic fibers: The missing key to improve engineering concepts for reconstruction of the Nucleus Pulposus in the intervertebral disc. Acta Biomater. 2020;113:407-416.
[17] MOHANTY S, DAHIA CL. Defects in intervertebral disc and spine during development, degeneration, and pain: New research directions for disc regeneration and therapy. Wiley Interdiscip Rev Dev Biol. 2019;8(4): e343.
[18] TANG X, JING L, RICHARDSON WJ, et al. Identifying molecular phenotype of nucleus pulposus cells in human intervertebral disc with aging and degeneration. J Orthop Res. 2016;34(8):1316-1326.
[19] WU H, SHANG Y, YU J, et al. Regenerative potential of human nucleus pulposus resident stem/progenitor cells declines with ageing and intervertebral disc degeneration. Int J Mol Med. 2018;42(4):2193-2202.
[20] ZHAO R, LIU W, XIA T, et al. Disordered Mechanical Stress and Tissue Engineering Therapies in Intervertebral Disc Degeneration. Polymers (Basel). 2019;11(7):1151.
[21] GE J, CHENG X, YUAN C, et al. Syndecan-4 is a Novel Therapeutic Target for Intervertebral Disc Degeneration via Suppressing JNK/p53 Pathway. Int J Biol Sci. 2020;16(5):766-776.
[22] LEUNG VYL, ZHOU L, TAM WK, et al. Bone morphogenetic protein-2 and -7 mediate the anabolic function of nucleus pulposus cells with discrete mechanisms. Connect Tissue Res. 2017;58(6):573-585.
[23] GU T, SHI Z, WANG C, et al. Human bone morphogenetic protein 7 transfected nucleus pulposus cells delay the degeneration of intervertebral disc in dogs. J Orthop Res. 2017;35(6):1311-1322.
[24] KIM JS, ELLMAN MB, AN HS, et al. Insulin-like growth factor 1 synergizes with bone morphogenetic protein 7-mediated anabolism in bovine intervertebral disc cells. Arthritis Rheum. 2010;62(12):3706-3715.
[25] WANG C, RUAN DK, ZHANG C, et al. Effects of adeno-associated virus-2-mediated human BMP-7 gene transfection on the phenotype of nucleus pulposus cells. J Orthop Res. 2011;29(6):838-845.
[26] WANG Z, HUTTON WC, YOON ST. The effect of capacitively coupled (CC) electrical stimulation on human disc nucleus pulposus cells and the relationship between CC and BMP-7. Eur Spine J. 2017;26(1):240-247.
[27] LI XC, WU YH, BAI XD, et al. BMP7-Based Functionalized Self-Assembling Peptides Protect Nucleus Pulposus-Derived Stem Cells From Apoptosis In Vitro. Tissue Eng Part A. 2016;22(19-20):1218-1228.
[28] CHAOFENG W, CHAO Z, DELI W, et al. Nucleus pulposus cells expressing hBMP7 can prevent the degeneration of allogenic IVD in a canine transplantation model. J Orthop Res. 2013;31(9):1366-1373.
[29] YANG P, TRONCONE L, AUGUR ZM, et al. The role of bone morphogenetic protein signaling in vascular calcification. Bone. 2020;141:115542.
[30] SAMPATH TK, VUKICEVIC S. Biology of bone morphogenetic protein in bone repair and regeneration: A role for autologous blood coagulum as carrier. Bone. 2020;141:115602.
[31] GONG C, PAN W, HU W, et al. Bone morphogenetic protein-7 retards cell subculture-induced senescence of human nucleus pulposus cells through activating the PI3K/Akt pathway. Biosci Rep. 2019;39(3): BSR20182312.
[32] ZHOU X, TAO Y, LIANG C, et al. BMP3 Alone and Together with TGF-beta Promote the Differentiation of Human Mesenchymal Stem Cells into a Nucleus Pulposus-Like Phenotype. Int J Mol Sci. 2015;16(9):20344-20359.
[33] XIE Z, JIE Z, WANG G, et al. TGF-beta synergizes with ML264 to block IL-1beta-induced matrix degradation mediated by Kruppel-like factor 5 in the nucleus pulposus. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(2): 579-589.
[34] TAN Y, YAO X, DAI Z, et al. Bone morphogenetic protein 2 alleviated intervertebral disc degeneration through mediating the degradation of ECM and apoptosis of nucleus pulposus cells via the PI3K/Akt pathway. Int J Mol Med. 2019;43(1):583-592.
[35] HUANG J, JIANG R, CHU X, et al. Overexpression of microRNA-23a-5p induces myocardial infarction by promoting cardiomyocyte apoptosis through inhibited of PI3K/AKT signalling pathway. Cell Biochem Funct. 2020;38(8):1047-1055.
[36] TAO H, CHENG L, YANG R. Downregulation of miR-34a Promotes Proliferation and Inhibits Apoptosis of Rat Osteoarthritic Cartilage Cells by Activating PI3K/Akt Pathway. Clin Interv Aging. 2020;15:373-385.
[37] SUN K, LUO J, GUO J, et al. The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthritis Cartilage. 2020;28(4): 400-409.